Trial Management STREAM

  1. CTIS Master Series 1: Are You Ready For CTIS? 3/22/2022

    In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.

  2. Secrets To A Collaborative Model To Improve TMF Management 10/30/2023

    Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.

  3. Modernizing Clinical Research With Patient-Centric Digital Data Collection 2/25/2025

    Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.

  4. End-To-End Clinical Data Flow 6/24/2024

    Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.

  5. Tackling The EU CTR Compliance Challenge 10/4/2018

    Maintaining disclosure compliance is tricky enough with ClinicalTrials.gov, but when it comes to EU CTR compliance, the complexity rises to a whole new level. As a sponsor, do you find your organization “guilty” of these common errors?

  6. Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy 5/4/2023

    Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.

  7. The New Era Of Project Optimus: Implications For Oncology Development Strategy 9/10/2025

    In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.

  8. Take A Look Inside The Pharmacodynamic Toolbox 1/30/2023

    This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials.

  9. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  10. Why Disclosure Assessments Are The First Step To Improvement 1/8/2019

    Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.